Coya Therapeutics (COYA) EPS (Diluted) (QoQ) (2022 - 2026)
Coya Therapeutics (COYA) EPS (Diluted) (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - |
| 10 | Coya Therapeutics | 97.60 Mn | 46.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.85% |
| Dec 31, 2025 | -76.26% |
| Sep 30, 2025 | 20.27% |
| Jun 30, 2025 | 16.61% |
| Mar 31, 2025 | 45.46% |
| Dec 31, 2024 | -45.80% |
| Sep 30, 2024 | -183.44% |
| Jun 30, 2024 | 44.52% |
| Mar 31, 2024 | 6.78% |
| Dec 31, 2023 | 17.69% |
| Sep 30, 2023 | -2.07% |
| Jun 30, 2023 | -8.97% |
| Mar 31, 2023 | 64.69% |
| Dec 31, 2022 | -12.84% |
| Sep 30, 2022 | 22.76% |
| Jun 30, 2022 | -102.67% |